Ironwood Pharmaceuticals Inc (IRWD)
3.44
+0.10
(+2.99%)
USD |
NASDAQ |
Nov 22, 16:00
3.42
-0.02
(-0.58%)
After-Hours: 20:00
Ironwood Pharmaceuticals Enterprise Value: 1.061B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 1.061B |
| November 21, 2024 | 1.045B |
| November 20, 2024 | 1.074B |
| November 19, 2024 | 1.120B |
| November 18, 2024 | 1.154B |
| November 15, 2024 | 1.184B |
| November 14, 2024 | 1.168B |
| November 13, 2024 | 1.200B |
| November 12, 2024 | 1.214B |
| November 11, 2024 | 1.276B |
| November 08, 2024 | 1.304B |
| November 07, 2024 | 1.256B |
| November 06, 2024 | 1.317B |
| November 05, 2024 | 1.229B |
| November 04, 2024 | 1.181B |
| November 01, 2024 | 1.181B |
| October 31, 2024 | 1.143B |
| October 30, 2024 | 1.175B |
| October 29, 2024 | 1.191B |
| October 28, 2024 | 1.175B |
| October 25, 2024 | 1.144B |
| October 24, 2024 | 1.147B |
| October 23, 2024 | 1.147B |
| October 22, 2024 | 1.163B |
| October 21, 2024 | 1.181B |
| Date | Value |
|---|---|
| October 18, 2024 | 1.215B |
| October 17, 2024 | 1.221B |
| October 16, 2024 | 1.231B |
| October 15, 2024 | 1.213B |
| October 14, 2024 | 1.197B |
| October 11, 2024 | 1.192B |
| October 10, 2024 | 1.184B |
| October 09, 2024 | 1.184B |
| October 08, 2024 | 1.175B |
| October 07, 2024 | 1.152B |
| October 04, 2024 | 1.199B |
| October 03, 2024 | 1.187B |
| October 02, 2024 | 1.192B |
| October 01, 2024 | 1.154B |
| September 30, 2024 | 1.170B |
| September 27, 2024 | 1.160B |
| September 26, 2024 | 1.167B |
| September 25, 2024 | 1.146B |
| September 24, 2024 | 1.160B |
| September 23, 2024 | 1.170B |
| September 20, 2024 | 1.205B |
| September 19, 2024 | 1.239B |
| September 18, 2024 | 1.240B |
| September 17, 2024 | 1.234B |
| September 16, 2024 | 1.232B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.045B
Minimum
Nov 21 2024
3.024B
Maximum
Feb 14 2024
1.797B
Average
1.768B
Median
Apr 22 2020
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
| iBio Inc | 14.05M |
| Theriva Biologics Inc | -12.68M |
| Oragenics Inc | 2.314M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 3.646M |
| Revenue (Quarterly) | 91.59M |
| Total Expenses (Quarterly) | 65.94M |
| EPS Diluted (Quarterly) | 0.02 |
| Profit Margin (Quarterly) | 3.98% |
| Earnings Yield | -0.87% |
| Operating Earnings Yield | 19.72% |
| Normalized Earnings Yield | 0.3197 |